Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday before market hours. Here’s what to look for.
Teleflex met analysts’ revenue expectations last quarter, reporting revenues of $700.7 million, down 5% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and constant currency revenue in line with analysts’ estimates.
Is Teleflex a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Teleflex’s revenue to be flat year on year at $770.9 million, slowing from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $3.37 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Teleflex has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Teleflex’s peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 21.4%, beating analysts’ expectations by 3.7%, and Penumbra reported revenues up 13.4%, topping estimates by 3.7%. Intuitive Surgical traded down 1.9% following the results.
Read our full analysis of Intuitive Surgical’s results here and Penumbra’s results here.
Investors in the healthcare equipment and supplies segment have had fairly steady hands going into earnings, with share prices down 1.8% on average over the last month. Teleflex is down 2.4% during the same time and is heading into earnings with an average analyst price target of $144.33 (compared to the current share price of $115.49).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.